BioSpace News Archive

Avista Establishes a New Pharmaceuticals Platform

Dicerna Pharmaceuticals, Inc. today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in three investor conferences in November.

KalVista Pharmaceuticals, Inc. today announced that it will present a corporate overview at the following upcoming investor conferences.

Partner Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine®.

Award-winning digital tools connect researchers and data providers to deliver tomorrow’s insights today

In acknowledgement of World Antibiotic Awareness Week, Nov. 12-18, a new survey examining Canadians’ understanding of antimicrobial resistance (AMR) reveals that many are unfamiliar with and unconcerned about the threat of drug resistance.1,2

MEI Pharma, Inc. today announced that Daniel P. Gold, Ph.D. will present a corporate update at the Stifel 2018 Healthcare Conference.

Halozyme Therapeutics today announced that Albert Kildani has joined the company in the role of vice president of investor relations and corporate communications.

Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of cell-delivered oncolytic viruses for the treatment of cancer, today announced that data from its clinical studies in late-stage cancer patients will be presented at the Society for Immunotherapy of Cancer (SITC) upcoming 33rd Annual Meeting,

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2018 results on Tuesday, November 13, and host a conference call the same morning at 9:00am EDT